Patents by Inventor Johan Angbrant

Johan Angbrant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sulfonyl-indole derivatives
    Patent number: 8138333
    Abstract: The present invention relates to novel compounds of formula (I): wherein R1, R2, R3, R4, and R5 are as described herein, to pharmaceutical compositions comprising the compounds, to processes for their preparation, as well as to the use of the compounds for the preparation of a medicament against 5-HT6 receptor-related disorders.
    Type: Grant
    Filed: March 13, 2008
    Date of Patent: March 20, 2012
    Assignee: Proximagen Limited
    Inventors: Johan Angbrant, Peter Brandt, Rune Ringom, Bengt Lindqvist
  • 4-substituted indole and indoline compounds
    Patent number: 7812017
    Abstract: The present invention relates to novel compounds of formula (I): wherein m, n, R0, R1, R2, R3 and R4 are as described herein, to pharmaceutical compositions comprising the compounds, to processes for their preparation, as well as to the use of the compounds for the preparation of a medicament against 5-HT6 receptor-related disorders.
    Type: Grant
    Filed: July 3, 2007
    Date of Patent: October 12, 2010
    Assignee: Biovitrum AB (publ.)
    Inventors: Johan Angbrant, Rune Ringom, Kristin Hammer, Erik Ringberg, Bengt Lindqvist, Gary Johansson, Peter Brandt, Katarina Beierlein, Björn M Nilsson
  • New compounds
    Publication number: 20080293694
    Abstract: The present invention relates to novel compounds of formula (I): wherein R1, R2, R3, R4, and R5 are as described herein, to pharmaceutical compositions comprising the compounds, to processes for their preparation, as well as to the use of the compounds for the preparation of a medicament against 5-HT6 receptor-related disorders.
    Type: Application
    Filed: March 13, 2008
    Publication date: November 27, 2008
    Applicant: Biovitrum AB (publ.)
    Inventors: Johan Angbrant, Peter Brandt, Rune Ringom, Bengt Lindqvist
  • Compounds
    Publication number: 20080039450
    Abstract: The present invention relates to compounds of the general formula I wherein X, Y, Z, A, Ar, R1, R2, R3, and R4 are as defined herein, which compounds are inhibitors of MNK2 and MNK1. The invention also relates to the use of the compounds in therapy, pharmaceutical compositions comprising the compounds, and the use of the compounds for the preparation of a medicament for the prophylaxis and treatment of disorders related to undesired activity of MNK1 and/or MNK2 kinases.
    Type: Application
    Filed: June 21, 2007
    Publication date: February 14, 2008
    Inventors: Annika Jensen, Rune Ringom, Carmen Medina, John Vock, Marie Wiik, Tobias Koolmeister, Johan Angbrant, Martin Henriksson, Teresa Sandvall, Lori Sutin, Lars Johannson, Bjorn Nilsson
  • New compounds
    Publication number: 20050239841
    Abstract: The invention relates to compounds of the general formula (I) wherein R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, Ar, and X are as defined in the description, or a pharmaceutically acceptable salt, hydrates, geometrical isomers, racemates, tautomers, optical isomers, N-oxides and prodrug forms thereof. The compounds may be used for the treatment or prophylaxis of disorders related to the MCH1R receptor and for modulation of appetite. The invention also relates to such use as well as to pharmaceutical formulations comprising a compound of formula (I).
    Type: Application
    Filed: November 24, 2004
    Publication date: October 27, 2005
    Inventors: Andrew Browning, Jonas Nilsson, Martin Scobie, Johan Angbrant, Rune Ringom